Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy

Journal of the National Cancer Institute

Volumn 90, Issue 3, 1998, Pages 210-218

  Van Dam, Frits S A M ^a,b   Schagen, Sanne B ^c   Muller, Martin J ^c   Boogerd, Willem ^a,d   V D Wall, Elsken ^c   Droogleever Fortuyn, Maria E ^c   Rodenhuis, Sjoerd ^c  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; TAMOXIFEN; THIOTEPA;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HIGH RISK POPULATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEUROPSYCHOLOGICAL TEST; RANDOMIZED CONTROLLED TRIAL;

EID: 0032481412     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.3.210     Document Type: Article

References (51)

1. ) McCarthy M. Unproven breast cancer therapy widely used in USA [news]. Lancet 1996;347:1617.
2. de Vries EG, ten Vergert EM, Mastenbroek CG, Dalesio O, Rodenhuis S. Breast cancer studies in The Netherlands. Lancet 1996;384:407-8.
3. Silberfarb PM, Philibert D, Levine PM. Psychosocial aspects of neoplastic disease: II. Affective and cognitive effects of chemotherapy in cancer patients. Am J Psychiatry 1980;137:597-601.
4. Oxman TE, Silberfarb PM. Serial cognitive testing in cancer patients receiving chemotherapy. Am J Psychiatry 1980;137:1263-5.
5. Parth P, Dunlap WP, Kennedy RS, Ordy JM, Lane NE. Motor and cognitive testing of bone marrow transplant patients after chemoradiotherapy. Percept Mot Skills 1989;68:1227-41.
6. Devlen J, Maguire P, Phillips P, Crowther D. Psychological problems associated with diagnosis and treatment of lymphomas. II: prospective study. Br Med J 1987;295:955-7.
7. Andrykowski MA, Schmitt FA, Gregg ME, Brady MJ, Lamb DG, Henslee-Downey PJ. Neuropsychologic impairment in adult bone marrow transplant candidates. Cancer 1992;70:2288-97.
8. Meyers CA, Abbruzzese JL: Cognitive functioning in cancer patients: effect of previous treatment. Neurology 1992;42:434-6.
9. Wieneke MH, Dienst ER. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-oncology 1995;4:61-6.
10. Meyers CA, Weitzner M, Byrne K, Valentine A, Champlin RE, Przepiorka D. Evaluation of the neurobehavioral functioning of patients before, during and after bone marrow transplantation. J Clin Oncol 1994;12:820-6.
11. Meyers CA, Byrne KS, Komaki R. Cognitive deficits in patients with small cell lung cancer before and after chemotherapy. Lung Cancer 1995;12: 231-5.
12. Cull A, Gregor A, Hopwood P, Macbeth F, Karnicka-Mlodkowska H, Thacher N, et al. Neurological and cognitive impairment on long-term survivors of small cell lung cancer. Eur J Cancer 1994;30A:1067-74.
13. Ahles TA, Tope DM, Furstenberg C, Hann D, Mills L. Psychologic and neuropsychologic impact of autologous bone marrow transplantation. J Clin Oncol 1996;14:1457-62.
14. Van Oosterhout AG, Ganzevles PG, Wilmink JT, De Geus BW, Van Vonderen RG, Twijnstra A. Sequelae in long-term survivors of small cell lung cancer. Int J Radiat Oncol Biol Phys 1996;5:1037-44.
15. Cull A, Hay C, Love SB, Mackie M, Smets E, Stewart M. What do patients mean when they complain of concentration and memory problems? Br J Cancer 1996;74:1674-9.
16. van der Wall E, Nooijen WJ, Baars JW, Holtkamp NJ, Schorangel JH, Richel DJ, et al. High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approach. Br J Cancer 1995;71:857-62.
17. Harris J, Morrow M, Norton L. Cancer of the breast. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles & practice of oncology. Vol 2. 5th ed. Philadelphia: Lippincott-Raven, 1997:1541-616.
18. Bouma A, Mulder J, Lindeboom J. Neuropsychologische diagnostiek. Handboek. Lisse: Swets & Zeitlinger, 1996.
19. Rey A. L'examen clinique en psychologie, 1964. Paris: Presses Universitaires de France.
20. Van den Burg W, Saan RJ, Deelman BG. 15-woordentest. Provisional Manual, 1985. Groningen: University Hospital, Department of Neuropsychology.
21. Rey A. L'examen psychologique dans les cas d'encephalopathie traumatique. Arch Psychol 1941;28:286-340.
22. Osterrieth PA. Le test de copie d'une figure complexe: contribution a l'etude de l'aperception et de la memoire. Arch Psychol 1944;30:205-353.
23. Wechsler D. Wechsler Adult Intelligence Scale. New York: Psychological Corporation, 1955.
24. Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-6.
25. Brickenkamp R. Test d2. Aufmerksamkeitsbelastungstest. Handanweisung. Gottingen: Hochrefe 1978.
26. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935;12:242-8.
27. Hammes JG. De Stroop kleur-woord test. Handleiding, tweede gewijzigde druk. Lisse: Swets & Zeitlinger, 1978.
28. Deelman BG, Liebrand WBG, Koning-Haanstra M, Burg van de W. S.A.N Test, een afasietest voor mondeling en auditief taalgebruik. Lisse: Swets en Zeitlinger B.V, 1881.
29. Alpherts WC, Aldenkamp AP. Fepsy. The iron Fepsy. Instituut voor epilepsiebestrijding Heemstede, 1994.
30. Schmand B, Lindeboom J, van Harskamp F. De Nederlandse Leestest voor Volwassenen. Lisse: Swets & Zeitlinger, 1992.
31. Berger H, Kunst M, Deelman BG. [Dutch Reading tests for adults]. Tijdschr Gerontol Geriatr 1996;27:250-4.
32. de Jonghe F, Huyser J, Swinkels J, Sno H, Schalken H. Depressie en Angst lijst. 1990.
33. Aaronson NK, Ahmedzi S, Bergman B, Bullinger M, Cull A. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76.
34. Lezak MD. Neuropsychological assessment, 3rd ed. New York: Oxford University Press. 1995.
35. Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L. Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer 1994;30A:37-40.
36. SPSS Benelux B.V. Gorichem, The Netherlands.
37. Vercoulen JH, Bazelmans E, Swanink CM, Galama JM, Fennis JF, Jongen PJ, et al. The prevalence of neuropsychological impairment in chronic fatigue syndrome. In: Vercoulen JH. Chronic Fatigue Syndrome: assessment and psychological processes as perpetuating factors. PhD thesis. Nijmegen: Catholic University Nijmegen, 1997:203-28.
38. Rosenthal R, Rubin DB. Multiple contrasts and ordered Bonferroni procedures. J Edu Psychol 1984;76:1028-34.
39. Sunderland A, Harris JE, Gleave. Memory failures in everyday life following severe head injury. J Clin Neuropsychol 1984;127-42.
40. Sunderland A, Watts K, Baddeley AD, Harris JE. Subjective memory assessment and test performance in elderly adults. J Gerontol 1986;41: 376-84.
41. Wilson B, Cockburn J, Baddeley A, Hiorns R. The development and validation of a test battery for detecting and monitoring everyday memory problems. J Clin Exp Neuropsychol 1989;11:855-70.
42. Vermeulen J, Aldenkamp AP, Alpherts WC. Memory complaints in epilepsy: correlations with cognitive performance and neuroticism. Epilepsy Res 1993;15:157-70.
43. Sherwin BB. Hormones, mood, and cognitive functioning in postmenopausal woman. Obstet Gynecol 1996;87:20-6.
44. Sherwin BB. Estrogen effects on cognition in menopausal woman. Neurology 1997;48(5 Suppl 7):S21-6.
45. Arpels JC. The female brain hypoestrogenic continuum from the premenstrual syndrome to menopause. A hypothesis and review of supporting data. J Reprod Med 1996;41:6339.
46. Peters WP. High-dose chemotherapy with autologous bone marrow transplantation for the treatment of breast cancer: Yes. In: DeVita VT, Hellman S, Rosenberg SA, editors. Important Advances in Oncology. Philadelphia: Lippincott-Raven, 1995:215-30.
47. Peters WP, Ross M, Vredenburgh JJ, Meisenberg B, Marks LB, Winer E, et al. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy tor high-risk primary breast cancer. J Clin Oncol 1993;6:1132-43.
48. Mulder NH, Sleijfer DTh, de Vries EG. Intensive chemotherapy with autologous bone marrow reinfusion in patients with breast cancer and more than 5 involved lymph nodes. Proc ASCO 1993;12:104.
49. Wolff SN, Herzig RH, Fay JW, LeMaistre CF, Brown RA, Frei-lahr D, et al. High-dose N, N′, N″-triethylenethiophosphoramide (thiopeta) with autologous bone marrow transplantation: phase I studies. Semin Oncol 1990;17(1 Suppl 3):2-6.
50. Baddeley A. Human memory. Theory and practice, 1990. Lawrence Erlbaum Associates.
51. Smith GA, Henderson IC. High-dose chemotherapy with autologous bone marrow transplantation for the treatment of breast cancer: The jury is still out. In: DeVita VT, Hellman S, Rosenberg SA, editors. Important advances in oncology. Philadelphia: Lippincott-Raven, 1995:201-14.